D-0530-2023 Class II Ongoing

Recalled by Hetero USA Inc — Piscataway, NJ

FDA drug recall D-0530-2023 was initiated by Hetero USA Inc on Mar 14, 2023 and is designated Class II. Reason for recall: CGMP Deviations: Discoloration The recall status is ongoing. Affected quantity: 2,352 bottles.

Recall details

Product Type
Drugs
Report Date
Apr 19, 2023
Initiation Date
Mar 14, 2023
Product Quantity
2,352 bottles

Product description

Pantoprazole Sodium Delayed Release Tablets USP 40mg, 1000-count bottles, Rx only, Manufactured for: Camber Pharmaceuticals Inc., Piscataway, NJ, 08854, By: Hetero Labs Limited, Unit V, Polepally, Jadcherla, Mahabubnagar- 509 301, India NDC 31722-713-10

Reason for recall

CGMP Deviations: Discoloration

Distribution pattern

Nationwide within the United States

Code information

Lot #: PAN22542, Exp. Date: 9/2024

Source

Dataset
openFDA drug recall enforcement reports
FDA record
This recall in openFDA (JSON)
Enforcement Report
Search FDA's Enforcement Report for D-0530-2023
openFDA file date
Nov 10, 2026
Loaded by RegDataLab
Nov 11, 2026

These dates say when openFDA published the data file and when RegDataLab last loaded it.

Source: openFDA record for D-0530-2023. Report a data issue: hello@regdatalab.com.